To further detect the effects of the LEP G2548A and LEPR Q223R polymorphisms on the elevation of CK levels in response to simvastatin treatment, we investigated the relationship between those genotypes and changes in CK levels after four and eight weeks of simvastatin treatment among patients with primary hyperlipidemia. Here, LEP is linked to hyperlipidemia.